Sanctuary Wealth Management »

BioMarin Pharmaceutical shares owned by Sanctuary Wealth Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Sanctuary Wealth Management from 13F filings

Historical chart of Sanctuary Wealth Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Sanctuary Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Sanctuary Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $867 9 96.44
2023-09-30 $795 9 88.44
2023-06-30 $780 9 86.67
2022-12-31 $930 9 103.44
2010-03-31 $874 9 97.22

More positions owned by Sanctuary Wealth Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Morningstar Grwt (ILCG)
Vanguard World Fds Inf Tech Etf (VGT)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard World Fds Consum Dis Etf (VCR)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Vanguard Index Fds Real Estate Etf (VNQ)
Axon Enterprise (AXON)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard World Fds Health Car Etf (VHT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Sanctuary Wealth Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical